Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery
- PMID: 19001022
- PMCID: PMC2892105
- DOI: 10.1161/CIRCULATIONAHA.108.804286
Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery
Abstract
Background: This study sought to determine whether associations exist between perioperative glucose exposure, prolonged hospitalization, and morbid events after complex congenital heart surgery.
Methods and results: Metrics of glucose control, including average, peak, minimum, and SD of glucose levels, and duration of hyperglycemia were determined intraoperatively and for 72 hours after surgery for 378 consecutive high-risk cardiac surgical patients. Multivariable regression analyses were used to determine relationships between these metrics of glucose control, hospital length of stay, and a composite morbidity-mortality outcome after controlling for multiple variables known to influence early outcomes after congenital heart surgery. Intraoperatively, a minimum glucose <or=75 mg/dL was associated with greater adjusted odds of reaching the composite morbidity-mortality end point (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.49 to 6.48), but other metrics of glucose control were not associated with the composite end point or length of stay. Greater duration of hyperglycemia (glucose >126 mg/dL) during the 72 postoperative hours was associated with longer duration of hospitalization (P<0.001). In the 72 hours after surgery, average glucose <110 mg/dL (OR, 7.30; 95% CI, 1.95 to 27.25) or >143 mg/dL (OR, 5.21; 95% CI, 1.37 to 19.89), minimum glucose <or=75 mg/dL (OR, 2.85; 95% CI, 1.38 to 5.88), and peak glucose level >or=250 mg/dL (OR, 2.55; 95% CI, 1.20 to 5.43) were all associated with greater adjusted odds of reaching the composite morbidity-mortality end point.
Conclusions: In children undergoing complex congenital heart surgery, the optimal postoperative glucose range may be 110 to 126 mg/dL. Randomized trials of strict glycemic control achieved with insulin infusions in this patient population are warranted.
Similar articles
-
Intraoperative glycemic control without insulin infusion during pediatric cardiac surgery for congenital heart disease.Paediatr Anaesth. 2011 Aug;21(8):872-9. doi: 10.1111/j.1460-9592.2011.03571.x. Epub 2011 Apr 4. Paediatr Anaesth. 2011. PMID: 21463390
-
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.Ann Intern Med. 2007 Feb 20;146(4):233-43. doi: 10.7326/0003-4819-146-4-200702200-00002. Ann Intern Med. 2007. PMID: 17310047 Clinical Trial.
-
Perioperative factors associated with hyperglycemia after pediatric cardiac surgery and impact of hyperglycemia on morbidity and mortality.Turk J Pediatr. 2018;60(5):497-505. doi: 10.24953/turkjped.2018.05.005. Turk J Pediatr. 2018. PMID: 30968624
-
Perioperative control of blood glucose level in cardiac surgery.Gen Thorac Cardiovasc Surg. 2013 Feb;61(2):61-6. doi: 10.1007/s11748-012-0198-9. Epub 2013 Jan 5. Gen Thorac Cardiovasc Surg. 2013. PMID: 23292688 Review.
-
Importance of perioperative blood glucose management in cardiac surgical patients.Asian Cardiovasc Thorac Ann. 2007 Dec;15(6):534-8. doi: 10.1177/021849230701500621. Asian Cardiovasc Thorac Ann. 2007. PMID: 18042786 Review.
Cited by
-
Disturbance of glucose homeostasis after pediatric cardiac surgery.Pediatr Cardiol. 2011 Feb;32(2):131-8. doi: 10.1007/s00246-010-9829-z. Epub 2010 Nov 17. Pediatr Cardiol. 2011. PMID: 21082177 Free PMC article.
-
Comparison of high glucose concentration blood and crystalloid cardioplegia in paediatric cardiac surgery: a randomized clinical trial.Interact Cardiovasc Thorac Surg. 2016 May;22(5):553-60. doi: 10.1093/icvts/ivv391. Epub 2016 Jan 31. Interact Cardiovasc Thorac Surg. 2016. PMID: 26831677 Free PMC article. Clinical Trial.
-
Prophylactic corticosteroids for infants undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials.BMC Anesthesiol. 2024 Oct 25;24(1):385. doi: 10.1186/s12871-024-02772-7. BMC Anesthesiol. 2024. PMID: 39455954 Free PMC article.
-
Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.Contemp Clin Trials. 2017 Feb;53:178-187. doi: 10.1016/j.cct.2016.12.023. Epub 2016 Dec 30. Contemp Clin Trials. 2017. PMID: 28042054 Free PMC article. Clinical Trial.
-
Hypoglycemia in critically ill children.J Diabetes Sci Technol. 2012 Jan 1;6(1):48-57. doi: 10.1177/193229681200600107. J Diabetes Sci Technol. 2012. PMID: 22401322 Free PMC article.
References
-
- Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118:173–179. - PubMed
-
- Yung M, Wilkins B, Norton L, Slater A. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med. 2008;9:147–152. - PubMed
-
- Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–1478. - PubMed
-
- Doenst T, Wijeysundera D, Karkouti K, Zechner C, Maganti M, Rao V, Borger MA. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical